Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1482
Source ID: NCT01125033
Associated Drug: Vitamin C & Vitamin E
Title: Study of Vitamin C, Vitamin E and Their Combination to Treat Restless Legs Syndrome in Hemodialysis Patients
Acronym: ShirazUMS
Status: COMPLETED
Study Results: NO
Results:
Conditions: Restless Legs Syndrome|Kidney Failure, Chronic
Interventions: DRUG: Vitamin C & Vitamin E|DRUG: Vitamin C|DRUG: Vitamin E|DRUG: Vitamin C Placebo & Vitamin E Placebo
Outcome Measures: Primary: Absolute Change in IRLS Sum Score, Absolute Change in IRLS Sum Score from Baseline to the End of Treatment Phase in Intention-to-treat Population, 8 Weeks | Secondary: Number of participants with adverse events, Number of participants with adverse events throughout the treatment phase of the study would be assessed., 8 Weeks
Sponsor/Collaborators: Sponsor: Shiraz University of Medical Sciences
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2|PHASE3
Enrollment: 60
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2008-03
Completion Date: 2009-02
Results First Posted:
Last Update Posted: 2011-06-17
Locations: Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of
URL: https://clinicaltrials.gov/show/NCT01125033